Results 171 to 180 of about 528,348 (385)

Positron emission tomography in cases of chorea with different underlying disease. [PDF]

, 1988
Alexander Lang, E.S. Garnett
openalex   +1 more source

AI in Neurology: Everything, Everywhere, All at Once Part 1: Principles and Practice

Annals of Neurology, EarlyView.
Artificial intelligence (AI) is rapidly transforming healthcare, yet it often remains opaque to clinicians, scientists, and patients alike. This review, part 1 of a 3‐part series, provides neurologists and neuroscientists with a foundational understanding of AI's key concepts, terminology, and applications.
Matthew Rizzo, Jeffrey D. Dawson
wiley   +1 more source

Concerning Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography. II [PDF]

, 1987
Barry R. Zeebèrg, Alden N. Bice, Henry N. Wagner   +2 more
openalex   +1 more source

AI in Neurology: Everything, Everywhere, all at Once PART 2: Speech, Sentience, Scruples, and Service

Annals of Neurology, EarlyView.
Artificial intelligence (AI) applications are finding use in real‐world neurological settings. Whereas part 1 of this 3‐part review series focused on the birth of AI and its foundational principles, this part 2 review shifts gears to explore more practical aspects of neurological care.
Matthew Rizzo
wiley   +1 more source

HIGH RESOLUTION POSITRON EMISSION TOMOGRAPHY USING SMALL BISMUTH GERMANATE CRYSTALS AND INDIVIDUAL PHOTOSENSORS [PDF]

, 1983
Stephen E. Derenzo, Thomas F. Budinger, T. Vuletich   +2 more
openalex   +1 more source

Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease

Annals of Neurology, EarlyView.
Objective The phenotype of patients with Parkinson's disease carrying GBA1 variants (GBA‐PD) suggest similarities to symptomatology associated with early cholinergic system degeneration. Therefore, this study aims to investigate the clinical features and the cholinergic innervation pattern in patients with early GBA‐PD versus those without the GBA1 ...
Sofie Slingerland, Sygrid van der Zee, Giulia Carli, Anne C. Slomp, Emile d'Angremont, Jeffrey M. Boertien, Teus van Laar   +6 more
wiley   +1 more source

Midlife Steroid‐Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women

Annals of Neurology, EarlyView.
Objective In men and women, sex steroid hormones have been associated with increased risk of Alzheimer's disease (AD) dementia. We aimed to investigate the influence of midlife testosterone and sex hormone binding globulin (SHBG) levels on later‐life in vivo markers of β‐amyloid (Aβ) and tau deposition in clinically healthy older men. Methods This time‐
Rachel F. Buckley, Matthew Scott, Emer R. McGrath, Gillian Coughlan, Mabel Seto, Saptaparni Ghosh, Heidi I. L. Jacobs, Claudia L. Satizabal, Emma Thibault, Vasan Ramachandran, Joanne M. Murabito, Reisa A. Sperling, Keith A. Johnson, Ravi Jasuja, Shalender Bhasin, Sudha Seshadri, Alexa S. Beiser   +16 more
wiley   +1 more source

Dataset of quantitative structured office measurements of movements in the extremities

Data in Brief, 2020
A low-cost quantitative structured office measurement of movements in the extremities of people with Parkinson's disease [1,2] was performed on people with Parkinson's disease, multiple system atrophy, and age-matched healthy volunteers.
Timothy P. Harrigan, Brian J. Hwang, Anil K. Mathur, Kelly A. Mills, Alexander Y. Pantelyat, Jee A. Bang, Alveena B. Syed, Pankhuri Vyas, Samuel D. Martin, Armaan Jamal, Liran Ziegelman, Manuel E. Hernandez, Dean F. Wong, James Robert Brašić   +13 more
doaj  

Quantitative measurement of renal plasma flow by positron emission tomography with oxygen-15 water.

, 1989
Tadashi INABA, Masato Yamashita, Yoshio Kawase, Hisamitsu Nakahashi, Hiroki Watanabe   +4 more
openalex   +2 more sources

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond

Annals of Neurology, EarlyView.
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Joseph J. Sabatino Jr., Bruce A. C. Cree, Stephen L. Hauser   +2 more
wiley   +1 more source